drugset / Trial / NCT03047291

Effect of Probiotic Lactobacillus Reuteri in the Treatment of Mucositis and Periimplantitis

NCT03047291

Phase 4 Completed 44 enrolled Universitat Internacional de Catalunya
RandomizedParallel-groupTriple-blindTreatment

Summary

Evaluate clinically and microbiologically the effect of the oral probiotic Lactobacillus reuteri Prodentis (PerioBalance®, Sunstar, Switzerland) on implants with mucositis or periimplantitis, as a coadjuvant treatment of mechanical therapy.

Timeline

Start
2014-01-01
Primary completion
2017-03-01
Completion
2017-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus reuteri Prodentis Other / unclassified Oral